chr19-14151199-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_014921.5(ADGRL1):āc.4084G>Cā(p.Glu1362Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000125 in 1,611,204 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014921.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152062Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000264 AC: 62AN: 234676Hom.: 0 AF XY: 0.000247 AC XY: 32AN XY: 129482
GnomAD4 exome AF: 0.000126 AC: 184AN: 1459024Hom.: 0 Cov.: 37 AF XY: 0.000134 AC XY: 97AN XY: 725790
GnomAD4 genome AF: 0.000118 AC: 18AN: 152180Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74396
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 15, 2021 | The c.4099G>C (p.E1367Q) alteration is located in exon 24 (coding exon 23) of the ADGRL1 gene. This alteration results from a G to C substitution at nucleotide position 4099, causing the glutamic acid (E) at amino acid position 1367 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at